Literature DB >> 12370400

TGF-beta and IL-13 synergistically increase eotaxin-1 production in human airway fibroblasts.

Sally E Wenzel1, John B Trudeau, Steve Barnes, XiuXia Zhou, Meghan Cundall, Jay Y Westcott, Kelly McCord, Hong Wei Chu.   

Abstract

Chronic diseases may involve an "innate" response followed by an adaptive immune response, of a Th1 or Th2 variety. Little is known regarding the interactions of these responses. We hypothesized that TGF-beta1 (innate response factor associated with wound repair) in combination with IL-13 (Th2 factor) might augment inflammatory processes associated with asthma. Airway fibroblasts were cultured from asthmatic subjects and normal controls. These fibroblasts were exposed to TGF-beta1 and IL-13 alone or in combination, and eotaxin-1 expression and production were evaluated. At 48 h, eotaxin-1 production was markedly increased with the combination of TGF-beta1 and IL-13 (p < 0.0001) compared with either stimulus alone. mRNA increased slightly at 1 h with IL-13 or TGF-beta1 plus IL13, peaked, and became significantly increased over IL-13 alone at 24 h. Protein was measurable from 6 h with IL-13 and TGF-beta1 plus IL-13, but greater levels were measured over time with the combination. Actinomycin ablated the increase in mRNA and protein seen with IL-13 alone and with TGF-beta1 plus IL-13. Cycloheximide blocked the increase in mRNA at 6 h in both conditions, but also blocked the increase at 24 h with TGF-beta1 plus IL-13. STAT-6 was rapidly activated with both IL-13 and the combination, without difference. Finally, eotaxin-1-positive fibroblasts were identified in severe asthma biopsies in greater numbers than in normals. These results support the concept that interactions of innate and adaptive immune systems may be important in promoting the tissue eosinophilia of asthma, particularly in those with more severe disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370400     DOI: 10.4049/jimmunol.169.8.4613

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  Regional fibroblast heterogeneity in the lung: implications for remodeling.

Authors:  Chakradhar Kotaru; Kathryn J Schoonover; John B Trudeau; Mai-Lan Huynh; XiuXia Zhou; Haizhen Hu; Sally E Wenzel
Journal:  Am J Respir Crit Care Med       Date:  2006-03-16       Impact factor: 21.405

2.  Surfactant protein A is defective in abrogating inflammation in asthma.

Authors:  Ying Wang; Dennis R Voelker; Njira L Lugogo; Guirong Wang; Joanna Floros; Jennifer L Ingram; Hong Wei Chu; Tony D Church; Pitchaimani Kandasamy; Daniel Fertel; Jo Rae Wright; Monica Kraft
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-07-22       Impact factor: 5.464

3.  Genomic differences distinguish the myofibroblast phenotype of distal lung fibroblasts from airway fibroblasts.

Authors:  Xiuxia Zhou; Wei Wu; Haizhen Hu; Jadranka Milosevic; Kazuhisa Konishi; Naftali Kaminski; Sally E Wenzel
Journal:  Am J Respir Cell Mol Biol       Date:  2011-07-14       Impact factor: 6.914

4.  Interleukin 10 and transforming growth factor beta contribute to the development of experimentally induced allergic conjunctivitis in mice during the effector phase.

Authors:  A Fukushima; T Sumi; K Fukuda; N Kumagai; T Nishida; H Yagita; H Ueno
Journal:  Br J Ophthalmol       Date:  2006-08-16       Impact factor: 4.638

5.  Airway TGF-β1 and oxidant stress in children with severe asthma: association with airflow limitation.

Authors:  Sheena D Brown; Katherine M Baxter; Susan T Stephenson; Annette M Esper; Lou Ann S Brown; Anne M Fitzpatrick
Journal:  J Allergy Clin Immunol       Date:  2011-12-28       Impact factor: 10.793

6.  Neutralisation of interleukin-13 in mice prevents airway pathology caused by chronic exposure to house dust mite.

Authors:  Kate L Tomlinson; Gareth C G Davies; Daniel J Sutton; Roger T Palframan
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

7.  Expression of CCR8 is increased in asthma.

Authors:  K Mutalithas; C Guillen; C Raport; R Kolbeck; D Soler; C E Brightling; I D Pavord; A J Wardlaw
Journal:  Clin Exp Allergy       Date:  2010-04-28       Impact factor: 5.018

8.  Janus kinase 1/3 signaling pathways are key initiators of TH2 differentiation and lung allergic responses.

Authors:  Shigeru Ashino; Katsuyuki Takeda; Hui Li; Vanessa Taylor; Anthony Joetham; Polly R Pine; Erwin W Gelfand
Journal:  J Allergy Clin Immunol       Date:  2013-12-22       Impact factor: 10.793

9.  The receptor for advanced glycation end products is a central mediator of asthma pathogenesis.

Authors:  Pavle S Milutinovic; John F Alcorn; Judson M Englert; Lauren T Crum; Tim D Oury
Journal:  Am J Pathol       Date:  2012-08-11       Impact factor: 4.307

Review 10.  Chronic inflammation and asthma.

Authors:  Jenna R Murdoch; Clare M Lloyd
Journal:  Mutat Res       Date:  2009-09-19       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.